OOIR: Observatory of International Research

Papers

(The H4-Index of Nature Reviews Nephrology is 64. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
A UMOD variant with intermediate effects	586
Mentorship in the lives of scholars	363
Daratumumab for AL amyloidosis	340
Kidney health within the broader non-communicable disease agenda	314
Age-old musings: twenty-first century management of advanced kidney disease in older individuals	289
Making advance care planning easier for adults with kidney disease and their clinicians	282
Role of the gut microbiota in the pathogenesis of IgA nephropathy	281
The GLP-1 receptor agonist revolution comes to nephrology	255
Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions	255
Vaccination in patients with kidney failure: lessons from COVID-19	246
Designing acute kidney injury clinical trials	210
Treatment of chronic kidney disease in older populations	198
Uropathogen and host responses in pyelonephritis	195
Disaster preparedness for patients with kidney disease	169
Genetic determinants of urine and plasma metabolite levels	167
A single-cell atlas of DKD treatment responses	162
Daprodustat for anaemia in CKD	161
Non-invasive molecular imaging of kidney diseases	156
Consideration of sex differences is necessary to achieve health equity	153
Beyond state borders: transforming dialysis care for undocumented immigrants	146
Roles of sensory receptors in non-sensory organs: the kidney and beyond	144
GWAS scorecard prioritizes kidney genes using coding and regulatory variants	137
Transport and barrier mechanisms that regulate ciliary compartmentalization and ciliopathies	136
Complosome — the intracellular complement system	136
Phosphate sensing via PTC glycolysis	135

Menopause and chronic kidney disease	131
Mutational signatures of ccRCC vary between geographical regions	123
Bringing Pride to nephrology	120
Interferon blockade in lupus: effects on antiviral immunity	118
Informing clinical decision making during a pandemic — a call for better preparedness	117
Reducing preventable acute kidney injury in a hospital setting	117
Publisher Correction: Sustainable Development Goals relevant to kidney health: an update on progress	116
Reference-trial-informed design to explore treatment effects in trial-underrepresented subgroups	113
Clonal haematopoiesis and AKI	112
Aquaporin water channels: roles beyond renal water handling	111
The roles of hyaluronan in kidney development, physiology and disease	111
Benefits of actin cytoskeleton stabilization	111
Increasing diversity and inclusion in nephrology clinical trials	111
Innovating dialysis through computational modelling of hollow-fibre haemodialysers	110
International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance)	108
From mapping kidney function to mechanism and prediction	106
Immunometabolic consequences of IL-23	105
ERA-EDTA congress 2021	101
NUAK1 promotes kidney fibrosis	98
Identification of erythropoietin-producing cells	98
Design of a renal-sparing antifungal	95
Tertiary lymphoid organs contribute to kidney allograft rejection	94
Heat and health inequity: acting on determinants of health to promote heat justice	91
Treatment of SLE with anti-CD19 CAR-T cells	88
From fat to filter: the effect of adipose tissue-derived signals on kidney function	87
Pathological mechanisms of kidney disease in ageing	86
Neutrophils and NETs in kidney disease	85
RNA-binding proteins and their role in kidney disease	82
Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics	81
Salt substitution: opportunities and challenges for nephrology	79
The role of complement in kidney disease	77
Long-term health outcomes associated with hydration status	77
The evolving landscape of immune-mediated glomerular diseases	75
Reaping the rewards of mechanistic discovery in glomerular disease	74
Author Correction: Chronic cardiovascular–kidney disorder: a new conceptual framework	73
MSC therapy for diabetic kidney disease and nephrotic syndrome	72
A golden year of innovative kidney disease therapeutics	70
Reducing stress-induced CHOP is renoprotective	69
Network medicine: an approach to complex kidney disease phenotypes	66